{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:27:36Z","timestamp":1787761656509,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mucormycosis, once a rare fungal disease, has now shown a surge in cases, and its epidemiology in India is intriguing. Rising incidence confers the necessity of defining the demography of the population at risk, early diagnosis, and recommendations for the management of mucormycosis in patients with coronavirus disease (COVID-19) infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To study the clinico-epidemological profile, risk factors, and histopathological features of COVID-19-associated Mucormycosis (CAM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and Design:<\/jats:title>\n                    <jats:p>This is a retrospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>Fifty-six biopsy specimens taken from patients of COVID-19 with clinical suspicion of mucormycosis were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Diabetes mellitus, corticosteroids, and oxygen therapy were the most common risk factors associated with CAM. The mean duration between the onset of symptoms of COVID-19 and onset of CAM was 25.2 \u00b1 15.3 days. Rhino-orbito-cerebral mucormycosis (ROCM) was present in 24.5% of the cases, with a survival rate of 58.3%. Histopathology showed tissue invasion by branching broad-based, pale, fungal hyphae consistent with mucor in 49 (87.5%) cases. Inflammation was acute neutrophilic type in 61.2% of the patients with a survival rate of 63.33%. The survival rate with chronic non-granulomatous and chronic granulomatous was 100% and 81.8%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Keeping a high index of suspicion for mucormycosis in COVID-19 by all medical fraternities of the health community in the existence of risk factors is the need of the hour for prompt diagnosis. Biopsy of antral necrotic tissue should be performed immediately after suspicion for histopathological study to confirm the diagnosis of mucormycosis and predict prognosis depending on the type of inflammation incited, fungal morphology, load, and necrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_192_22","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T01:16:19Z","timestamp":1675127779000},"page":"106-110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The baneful alliance of COVID-19 and mucormycosis"],"prefix":"10.4103","volume":"66","author":[{"given":"Anshu","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20240829","first-page":"100057","article-title":"Mucormycosis in COVID-19 pandemic: Risk factors and linkages","volume":"2","author":"Kumar","year":"2021","journal-title":"Curr Res Microb Sci"},{"key":"R2-20-20240829","doi-asserted-by":"crossref","first-page":"100153","DOI":"10.1016\/j.puhip.2021.100153","article-title":"Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items","volume":"2","author":"Moona","year":"2021","journal-title":"Public Health Pract (Oxf"},{"key":"R3-20-20240829","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment, 2019","volume":"57","author":"Prakash","year":"2019","journal-title":"Med Mycol"},{"key":"R4-20-20240829","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and mucormycosis superinfection: The perfect storm","volume":"49","author":"Al-Tawfiq","year":"2021","journal-title":"Infection"},{"key":"R5-20-20240829","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01932420","article-title":"Mycosis mucorina","volume":"102","author":"Platauf","year":"1885","journal-title":"Virchows Arch"},{"key":"R6-20-20240829","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/mmy\/myu086","article-title":"A prospective study of mucormycosis in north India: Experience from a tertiary care Hospital","volume":"53","author":"Bala","year":"2015","journal-title":"Med Mycol"},{"key":"R7-20-20240829","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13693780500464930","article-title":"The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus","volume":"44","author":"Chakrabarti","year":"2006","journal-title":"Med Mycol"},{"key":"R8-20-20240829","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: Experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad Med J"},{"key":"R10-20-20240829","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1439-0507.2007.01382.x","article-title":"Zygomycosis: A case report and review of disease in India","volume":"50","author":"Diwakar","year":"2007","journal-title":"Mycoses"},{"key":"R12-20-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40475-020-00222-1","article-title":"Host-pathogen molecular factors contribute to the pathogenesis of Rhizopus spp. in diabetes mellitus","volume":"8","author":"Morales-Franco","year":"2021","journal-title":"Curr Trop Med Rep"},{"key":"R13-20-20240829","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S0950268805004930","article-title":"Mucormycosis in the Eastern Mediterranean: A seasonal disease","volume":"134","author":"Al-Ajam","year":"2006","journal-title":"Epidemiol Infect"},{"key":"R14-20-20240829","first-page":"1","article-title":"COVID-19-associated mucormycosis: An updated systematic review of literature","volume":"00","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"R15-20-20240829","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated mucormycosis (CAM): Case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"R16-20-20240829","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids\u2014An unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"R17-20-20240829","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/myc.13353","article-title":"Mucormycosis and COVID-19: An epidemic within a pandemic in India","volume":"64","author":"Selarka","year":"2021","journal-title":"Mycoses"},{"key":"R18-20-20240829","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.2147\/OPTH.S324977","article-title":"Rhino-orbito-cerebral-mucormycosis during the COVID-19 second wave in 2021-A preliminary report from a single hospital","volume":"15","author":"Arora","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R19-20-20240829","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India diabetes & metabolic syndrome","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R20-20-20240829","first-page":"243","article-title":"Pulmonary defense mechanisms against opportunistic fungal pathogens","volume":"47","author":"Waldorf","year":"1989","journal-title":"Immunol Ser"},{"key":"R21-20-20240829","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5005\/jp-journals-10071-23387","article-title":"Mucormycosis in a tertiary care center in South India: A 4-year experience","volume":"24","author":"Priya","year":"2020","journal-title":"Indian J Crit Care Med"},{"key":"R22-20-20240829","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18231\/j.achr.2021.033","article-title":"Invasive mucormycosis in post COVID-19 infection: Case report with review","volume":"6","author":"Jagtap","year":"2021","journal-title":"IP Arch Cytol Histopathol Res"},{"key":"R24-20-20240829","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/iai.38.1.292-297.1982","article-title":"Monocyte mediated damage to Rhizopus oryzae hyphae in vitro","volume":"38","author":"Diamond","year":"1982","journal-title":"Infect Immun"},{"key":"R25-20-20240829","first-page":"374","article-title":"Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: A ten-year retrospective review at a single institution","volume":"13","author":"Sangoi","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R26-20-20240829","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0377-4929.64342","article-title":"Role of histopathology as an aid to prognosis in rhinoorbito-cerebral zygomycosis","volume":"53","author":"Goel","year":"2010","journal-title":"Indian J Path Microbiol"},{"key":"R27-20-20240829","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1078\/0344-0338-00034","article-title":"Long term survival in acute rhinocerebral mucormycosis with giant cell arteritis and foreign body granulomas","volume":"197","author":"Castillo","year":"2001","journal-title":"Pathol Res Pract"},{"key":"R28-20-20240829","first-page":"e16152","article-title":"Coronavirus disease-associated mucormycosis from a tertiary care hospital in India: A case series","volume":"13","author":"Singh","year":"2021","journal-title":"Cureus"},{"key":"R29-20-20240829","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_192_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:02:57Z","timestamp":1787760177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_192_22"}},"subtitle":["Histopathological concerns"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_192_22","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}